MedTrace Logo

Nosocomial Transmission of MDR-TB in Bucharest, Romania

NCT02413931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2024-04-11

No results posted yet for this study

Summary

It is a single-center, observational, prospective cohort study recruiting patients hospitalized at the multidrug-resistant tuberculosis ward at Marius Nasta Institute. This project aims to improve the individual patient management and TB treatment outcomes, especially for patients with drug-resistant TB and/or co-morbidities. The study will be conducted in a co-operation between the Marius Nasta Institute, Division of Infectious Diseases \& Tropical Medicine of Klinikum of the University of Munich (KUM) and the German Center for Infection Research (DZIF).

Conditions

  • Tuberculosis, Multidrug-resistant

Interventions

OTHER

Routine management practices applied

all patients will be treated according to routine procedures, no intervention

Sponsors & Collaborators

  • "Marius Nasta" Pulmonology Institute

    collaborator OTHER

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • Research Center Borstel

    lead OTHER

Principal Investigators

  • Christoph Lange, MD, PhD · Research Center Borstel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02413931 on ClinicalTrials.gov